パーキンソン病におけるGPiパリドトミーの運動機能への影響
A M Lozano1, A E Lang, N Galvez-Jimenez
1Department of Surgery, Toronto Hospital Neurological Centre, Canada.
Lancet (London, England)
|November 25, 1995
まとめ
パーキンソン病の運動症状は,グローブス・パリドゥス内部 (GPi) パリドトミー手術で改善されました. この手順は,遅さや硬さを軽減し,患者の非自発的な運動障害を排除しました.
科学分野:
- 神経外科は神経外科です.
- 神経学 神経学とは
- 運動障害 運動障害
背景:
- パーキンソン病 (PD) の運動欠陥は,過度に活発なグローブス・パリドゥス・インターナル (GPi) から生じる.
- 過剰なGPi活動は,モーター・タラマスと皮質を抑制し,ブラディキネシアや硬直性などのPD症状を引き起こす.
研究 の 目的:
- パリドトミーによるGPi活性低下がPD患者の運動機能を改善するかどうかを調査する.
- アキネシア,歩行,姿勢の不安定性,およびレボドーパ誘発性運動不全に対するGPiのパリドトミーの影響を評価する.
主な方法:
- 14人のパーキンソン病患者でGPiパリドトミーを行った.
- GPiの位置は,傷害前にマイクロ電極記録によって確認されました.
- 盲目の評価者によって評価された,手術前・後の標準化されたビデオ記録.
主要な成果:
- 手術後6ヶ月で顕著な運動改善が観察されました.
- トータルモータースコアは30%,アキネシアは33%,歩行は15%,姿勢不安定/歩行は"オフ"状態で23%改善した.
- 逆側運動不全の92%の減少;視覚的または皮質脊髄の合併症は報告されていません.
結論:
- GPiパリドトミーは,パーキンソン病における運動能力を効果的に改善します.
- この処置はアキネシアを軽減し,歩行を改善し,レボドーパ誘発性運動障害を排除します.
- パリドトミーは,パーキンソン病の運動症状の管理のために安全で効果的な外科的選択肢です.
関連する概念動画
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...